Clinical Manifestation, Auxiliary Examination Features, and Prognosis of Visual Impairment Associated with Herpes Infection: A Cohort Study
Lei Liu1, Jingxiao Zhang1, Jiawei Wang1
1Beijing Tongren Hospital, Capital Medical University
Objective:
Exploring the clinical characteristics of patients with visual impairment after herpes virus infection.
Background:

Herpes virus family including herpes simplex virus (HSV), varicella-zoster virus (VZV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), and pseudorabies virus (PRV). Herpes virus infections may accompany with dermatological, ophthalmological, neurological complications. Viral acute retinal necrosis (ARN) present with rapidly progressive necrotizing retinitis and vasculitis. And optic neuritis (ON) is a rare complication of the eye associated with viral encephalitis. Lack of awareness of herpes related visual impairment often leads to postponed diagnosis and treatment.

Design/Methods:
The clinical data of 13 consecutive patients with visual impairment after herpes virus infection managed at the Department of Neurology at Beijing Tongren Hospital, Beijing, China, from January 1st 2016, to December 1st, 2022, were analyzed in this study.
Results:

A total of 13 patients with a median age at onset of 50.5 years (range 31-66) were included in the study. The types of herpes virus infections included VZV, HSV, EBV, and PRV, with VZV being the most common positive in 10 patients (76.9%). Diagnoses related to vision loss included optic neuritis (ON; 7, 53.8%), peripapillary ON (1, 7.7%), and acute retinal necrosis (ARN; 5, 38.5%). All 10 cases of VZV infection had signal abnormalities involving either optic nerve or optic nerve sheath, including one with combined meningeal involvement and another with brain parenchyma. The remaining three cases of HSV, EBV, and PRV infections combined with viral encephalitis had parenchymal involvement. All patients received both steroids and antiviral treatments. The duration to start intravenous (i.v) antiviral therapy ranged from 5 to 39 days, with a median time of 16 days.

Conclusions:

The clinical presentation of visual impairment after herpes virus infection is heterogeneous. With a lack of clinical awareness and delays in diagnosis and treatment, prognoses of these entities are disastrous. 

10.1212/WNL.0000000000211709
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.